Microsatellite instability is associated with genetic alteration but not with low levels of expression of the human mismatch repair proteins hMSH2 and hMLH1

European Journal of Cancer

Volumn 36, Issue 7, 2000, Pages 925-931

  Shin, K H ^a   Park, J G ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

hMLH1; hMSH2; Human gastric carcinoma cell lines; Microsatellite instability; MNNG tolerance

Indexed keywords

ALKYLATING AGENT; METHYLNITRONITROSOGUANIDINE; PROTEIN;

ARTICLE; BASE MISPAIRING; CANCER CELL; CARCINOMA CELL; CONTROLLED STUDY; DNA REPAIR; GENETIC ANALYSIS; HUMAN; HUMAN CELL; METHYLATION; MICROSATELLITE INSTABILITY; MUTATION; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CARCINOMA; WESTERN BLOTTING;

BASE PAIR MISMATCH; BLOTTING, NORTHERN; BLOTTING, WESTERN; CARRIER PROTEINS; DNA-BINDING PROTEINS; HUMANS; METHYLATION; MICROSATELLITE REPEATS; MUTATION; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0034095091     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00025-3     Document Type: Article

References (39)

1. Fishel R., Lescoe M.K., Rao M.R.et al. The human mutator gene homologue MSH2 and its association with hereditary nonpolyposis colon cancer. Cell. 75:1993;1027-1038.
2. Bronner C.E., Baker S.M., Morrison P.T.et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary nonpolyposis colon cancer. Nature. 368:1994;258-261.
3. Han H.-J., Yuan Y., Ku J.-L.et al. Germline mutations of hMLH1 and hMSH2 genes in Korean hereditary nonpolyposis colorectal cancer. J. Natl. Cancer Inst. 88:1996;1317-1319.
4. Nicolaides N.C., Papadopoulos N., Liu B.et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature. 371:1994;75-80.
5. Akiyama Y., Sato H., Yamada T.et al. Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred. Cancer Res. 57:1997;3920-3923.
6. Shin K.-H., Ku J.-L., Park J.-G. Germline mutations in a polycytosine repeat of the hMSH6 gene in Korean hereditary nonpolyposis colorectal cancer. J. Hum. Genet. 44:1999;18-21.
7. Papadopoulos N., Lindblom A. Molecular basis of HNPCC. mutations of MMR genes Hum. Mutat. 10:1997;89-99.
8. Modrich P., Lahue R. Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annu. Rev. Biochem. 65:1996;101-133.
9. Kolodner R.D. Mismatch repair. mechanisms and relationship to cancer susceptibility Trends Biochem. Sci. 20:1995;397-401.
10. Parsons R., Myeroff L., Liu B.et al. Microsatellite instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res. 55:1995;5548-5550.
11. Rampino N., Yamamoto H., Ionov Y.et al. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science. 275:1997;967-969.
12. Ouyang H., Shiwaku H.O., Hagiwara H.et al. The insulin-like growth factor II receptor gene is mutated in genetically unstable cancers of the endometrium, stomach, and colorectum. Cancer Res. 57:1997;1851-1854.
13. Risinger J.I., Umar A., Boyd J., Berchuck A., Kunkel T.A., Barrett J.C. Mutation of MSH3 in endometrial cancer and evidence for its functional role in heteroduplex repair. Nature Genet. 14:1996;102-105.
14. Yin J., Kong D., Wang S.et al. Mutation of hMSH3 and hMSH6 mismatch repair genes in genetically unstable human colorectal and gastric carcinomas. Hum. Mutat. 10:1997;474-478.
15. Papadopoulos N., Nicolaides N.C., Wei Y.F.et al. Mutation of a mutL homologue in hereditary colon cancer. Science. 263:1994;1625-1629.
16. Umar A., Boyer J.C., Thomasm D.C.et al. Defective mismatch repair in extracts of colorectal and endometrial cancer cell lines exhibiting microsatellite instability. J. Biol. Chem. 269:1994;14367-14370.
17. Risinger J.I., Umar A., Boyer J.C.et al. Microsatellite instability in gynecological sarcomas and hMSH2 mutant uterine sarcoma cell lines defective in mismatch repair activity. Cancer Res. 55:1995;5664-5669.
18. Liu B., Nicolaides N.C., Markowitz S.et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nature Genet. 9:1995;48-55.
19. + tumor cells. Cell. 74:1993;1227-1236.
20. Koi M., Umar A., Chauhan D.P.et al. Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N′-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. Cancer Res. 54:1994;4308-4312.
21. Shin K.-H., Yang Y.-M., Park J.-G. Absence or decreased levels of the hMLH1 protein in human gastric carcinoma cell lines. implication of hMLH1 in alkylation tolerance J. Cancer Res. Clin. Oncol. 124:1998;421-426.
22. Kat A., Thilly W.G., Fang W., Longley M.J., Li G.M., Modrich P. An alkylation-tolerance, mutator human cell line is deficient in strand-specific mismatch repair. Proc. Natl. Acad. Sci. USA. 90:1993;6424-6428.
23. Liu L., Markowitz S., Gerson S.L. Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea. Cancer Res. 56:1996;5375-5379.
24. D'Atri S., Graziani G., Lacal P.M.et al. Role of mismatch repair in apoptosis induced by methyltriazenes. Proc. Am. Assoc. Cancer. Res. 38:1997;1.
25. Friedman H.S., Johnson S.P., Dong Q.et al. Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograft. Cancer Res. 57:1997;2933-2936.
26. Karran P., Bignami M. DNA damage tolerance, mismatch repair and genome instability. BioEssays. 16:1995;833-839.
27. Park J.-G., Frucht H., LaRocca R.V.et al. Characteristics of cell lines established human gastric carcinoma. Cancer Res. 50:1990;2773-2780.
28. Park J.-G., Yang H.-K., Kim W.H.et al. Establishment and characterization of human gastric carcinoma cell lines. Int. J. Cancer. 70:1997;443-449.
29. Park K., Kim S.-J., Bang Y.-J.et al. Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells. correlation with sensitivity to growth inhibition by TGF-β Proc. Natl. Acad. Sci. USA. 91:1994;8772-8776.
30. Myeroff L.L., Parsons R., Kim S.-J.et al. A transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res. 55:1995;5545-5547.
31. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning. A Laboratory Manual 2nd edn. 1989;Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
32. Shin K.-H., Min B.-M., Cherrick H.M., Park N.-H. Combined effects of human papillomavirus-18 and N-methyl-N′-nitro-N-nitrosoguanidine on the transformation of normal oral keratinocytes. Mol. Carcinogenesis. 9:1994;76-86.
33. Lassar A.B., Davis R.L., Wright W.E.et al. Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell. 66:1991;305-315.
34. Kane M.F., Loda M., Gaida G.M.et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 57:1997;808-811.
35. Hoang J.-M., Cottu P.H., Thuille B., Salmon R.J., Thomas G., Hamelin R. BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res. 57:1997;300-303.
36. Herman J.G., Umar A., Polyak K.et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl. Acad. Sci. 95:1998;6870-6875.
37. Chauhan D.P., Yang Q.H., Marra G.et al. Proficiency of mismatch repair activity can be retained in spite of low expression levels of the hMLH1 gene in the HCT116 colon cancer cell line. Gastroenterology. 45(4SS):1996;A502.
38. Fink D., Aebi S., Howell S.B. The role of DNA mismatch repair in drug resistance. Clin. Cancer Res. 4:1998;1-6.
39. Dosch J., Christmann M., Kaina B. Mismatch G-T binding activity and MSH2 expression is quantitatively related to sensitivity of cells to methylating agents. Carcinogenesis. 19:1998;567-573.